Blog Category

Tag: Hopen Life Science Ventures

Navigate all the resources featured in the Landscape Guide by geographic location, industry sector, and organization type. Landscape Guide
Everything you need to know to make a meaningful first connection can be found in our 2021-22 Landscape Guide! Download the Guide

2023 MVCA Research Report

Our state's entrepreneurial economy hinges on our ability to provide capital to our high-growth, high-potential companies. Download the Report

Upcoming Events

Learn More
September 14 MEMBER NEWS: Beringea invests in record $39.5 million Series C Round for Delphinus Medical Technologies

FARMINGTON HILLS, MICH. (September 10, 2015)— Beringea, a private equity firm providing growth capital to market-leading businesses, is pleased to announce a follow-on investment in Delphinus Medical Technologies, Inc., the leader in advanced breast ultrasound technology.  The company has secured an unprecedented Series C funding round of $39.5 million, the single largest amount ever raised for a […]
Read More
April 24 ProNAi Therapeutics Raises $59.5M Series D Round for Phase II Clinical Trials

ProNAi Therapeutics Inc . has collected $59.5 million after clinical studies showed that its lead drug could help non-Hodgkin’s lymphoma patients who are running out of options.
Read More
February 20 Hopen Life Science Ventures’ Expert Team Committed to Creating Culture of Innovation in Michigan

Between its two funds, Hopen manages more than $65 million, which it prefers to invest in the region.

Read More
August 04 Member Press Release: Hopen Life Science Ventures Fund II Reaches $25 Million Initial Close and Announces First Four Investments

Fund II is second life science fund managed by West Michigan-based Hopen Life Science Ventures Grand Rapids, Mich.– Hopen Life Science Ventures, a Grand Rapids-based life science venture capital fund, announced an initial close of $25 million for its second fund, Hopen Life Science Fund II.  The fund will remain open to new limited partners […]
Read More